20 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
agents There are ... risks, and therapy should ... #pharmacology #pharmacotherapy ... table #comparison #management ... #medications #diabetes
Anterior Shoulder Dislocation - ED Management
The shoulder is the most commonly dislocated major joint, 95% of
Anterior Shoulder ... Dislocation - ED Management ... rotated, extended arm ... ) • ED Management ... #Orthopedics #Sports
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... clinic patients should ... #Pharmacology # ... Management #Medications
Orthopedic Dislocations (Shoulder, Elbow and Hip) - Diagnosis and Management Summary
Shoulder Dislocation
 • Fall on the
Orthopedic Dislocations ... Diagnosis and Management ... rotation) • Anterior ... (most common), Anterior ... Affected hip and knee
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... recommends, metformin should ... and CKD should ... evidence-based pharmacologic ... metformin #ACEi #ARB
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
getting patients on medication ... with HFrEF, we should ... both of these medications ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
” IL-6 levels are ... Total dose should ... Tocilizumab should ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
Neonatal Resuscitation – Circulation and Drugs
Consider drugs (k) if heart rate beats/min in spite of adequate
Drugs should be ... peripheral vein are ... Resuscitation #Drugs #Medications ... #Pharmacology # ... management #peds
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... Patients should ... been shown non-inferior ... #semaglutide #Diabetes ... #Pharmacology #
Medial Knee Intra-articular Corticosteroid Injection 

Injection of medial knee with intra-articular steroid. Find the inferior part
Medial Knee Intra-articular ... Find the inferior ... pads if present are ... where you should ... procedure #msk #orthopedics